Clinical Trial Update: Obestatin Change in Distal Gastrectomy

View source ↗

Summary

Clinical trial update on obestatin in gastric cancer patients undergoing distal/subtotal gastrectomy; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Obestatin (obestatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer Patients Treated by Subtotal Gastrectomy | Status: COMPLETED